MedTrace Logo

Tolerability and Pharmacokinetics of BIIB 722 CL Drinking Solution and of BIIB 722 CL Filmcoated Tablet in Healthy Subjects

NCT02227030 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 71

Last updated 2014-08-27

No results posted yet for this study

Summary

Safety and pharmacokinetics after oral single rising doses of BIIB 722 CL

Conditions

  • Healthy

Interventions

DRUG

BIIB 722 CL solution

DRUG

BIIB 722 CL tablet

DRUG

Placebo solution

DRUG

Placebo tablet

Sponsors & Collaborators

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2000-04-30
Primary Completion
2000-09-30

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02227030 on ClinicalTrials.gov